Literature DB >> 27751969

Coexistence of Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia.

Ivana Milosevic1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27751969      PMCID: PMC5204195          DOI: 10.4274/tjh.2016.0106

Source DB:  PubMed          Journal:  Turk J Haematol        ISSN: 1300-7777            Impact factor:   1.831


× No keyword cloud information.
A 76-year-old man presented with leukocytosis (86x109/L), fever, pneumonia, and significant weight loss. He had a history of chronic lymphocytic leukemia diagnosed 5 years earlier and he responded with partial remission to treatment with continuous low doses of chlorambucil. Analysis of the blood smear, bone marrow aspiration, and bone marrow biopsy revealed the predomination of small lymphocytes, but 22% of the cells were blasts negative with cytochemical staining (Figure 1). Flow cytometric analysis showed two distinct populations: 65% of cells were small to moderate in size and CD19+, CD45+, CD5+, and CD20+/-, while 30% of cells were large, CD34+, CD13+, HLA DR+, CD65+, CD45+, and MPO weakly positive and CD33, CD14, CD15, and CD16 negative. Immunophenotyping confirmed the coexistence of chronic lymphocytic leukemia and poorly differentiated acute myeloid leukemia. Conventional cytogenetic testing did not show any chromosomal abnormalities.
Figure 1

Chronic lymphocytic leukemia cells and acute myeloid leukemia cells in the peripheral blood smear.

The patient was treated with intensive antibiotherapy and received one course of chemotherapy, but he did not achieve remission and died 2 months later. The coexistence of chronic lymphocytic leukemia and acute myeloid leukemia is rare [1]. Therapy-related acute myeloid leukemia can develop after treatment of chronic lymphocytic leukemia with alkylating agents, nucleoside analogs, or combination chemotherapy, but the two leukemias can also originate independently [2,3]. Conflict of Interest: The author of this paper has no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included.
  3 in total

1.  Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome.

Authors:  F P Tambaro; G Garcia-Manero; S M O'Brien; S H Faderl; A Ferrajoli; J A Burger; S Pierce; X Wang; K-A Do; H M Kantarjian; M J Keating; W G Wierda
Journal:  Leukemia       Date:  2015-08-20       Impact factor: 11.528

2.  Therapy-related leukemia and myelodysplasia: susceptibility and incidence.

Authors:  Giuseppe Leone; Livio Pagano; Dina Ben-Yehuda; Maria Teresa Voso
Journal:  Haematologica       Date:  2007-10       Impact factor: 9.941

3.  Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.

Authors:  Vicki A Morrison; Kanti R Rai; Bercedis L Peterson; Jonathan E Kolitz; Laurence Elias; Frederick R Appelbaum; John D Hines; Lois Shepherd; Richard A Larson; Charles A Schiffer
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.